壓力與冠心病的相關(guān)性研究及越鞠丸對(duì)壓力致病的干預(yù)作用
發(fā)布時(shí)間：2018-08-21 08:15
【摘要】：目的：1.將有關(guān)可感知的壓力與冠心病關(guān)系的前瞻性隊(duì)列研究進(jìn)行匯總,用meta分析合并統(tǒng)計(jì)量,對(duì)可感知的壓力與冠心病的相關(guān)性進(jìn)行研究；2.觀察壓力下大鼠血清中炎癥反應(yīng)標(biāo)志物含量的變化,從炎癥的角度來(lái)探討壓力對(duì)冠心病發(fā)病的促進(jìn)作用；并用越鞠丸進(jìn)行干預(yù),觀察中醫(yī)藥在壓力致炎癥發(fā)生中的干預(yù)作用,進(jìn)一步闡明越鞠丸的功效,充分發(fā)揮中醫(yī)藥的優(yōu)勢(shì),尋找預(yù)防壓力所致冠心病的有效方法。方法：1. meta分析：首先確定文獻(xiàn)的納入/排除標(biāo)準(zhǔn),其次在Pubmed, EMBASE, The Cochrane Library這三大外文數(shù)據(jù)庫(kù)中進(jìn)行檢索,檢索時(shí)間是1990年1月一直到2016年2月,關(guān)鍵詞為冠心病及心理壓力的主題詞和自由詞。檢索結(jié)束后,導(dǎo)入Endnote軟件,對(duì)檢索的結(jié)果合并,去掉重復(fù)文獻(xiàn)。挑選合格的研究,對(duì)納入的研究進(jìn)行質(zhì)量評(píng)價(jià);并在符合納入標(biāo)準(zhǔn)的研究中提取所需信息,將數(shù)據(jù)錄入Revman5.3進(jìn)行統(tǒng)計(jì)量匯總。2.動(dòng)物實(shí)驗(yàn)：分為空白組,生理鹽水組,越鞠丸低倍劑量組,越鞠丸高倍劑量組,黛力新組(西藥組)5組。對(duì)后4組施予壓力刺激,并予相應(yīng)藥物灌胃,每日1次,持續(xù)3周。之后,取大鼠血清檢測(cè)血清皮質(zhì)酮、IL-6、 hs-CRP、 sICAM-1,主動(dòng)脈組織檢測(cè)E選凝素。結(jié)果：1.Meta分析共納入8項(xiàng)研究,8項(xiàng)研究中有1項(xiàng)的終點(diǎn)事件是冠心病確診與死亡之和,1項(xiàng)分別列出了確診與死亡的RR,3項(xiàng)終點(diǎn)事件為確診,3項(xiàng)為死亡；8項(xiàng)研究中,2項(xiàng)采用了通用的壓力測(cè)定量表,其余研究均讓受試者對(duì)自己感受的壓力進(jìn)行評(píng)分,根據(jù)分?jǐn)?shù)歸到不同的壓力組中；受試者的例數(shù)除1項(xiàng)研究為211外,其余均在1000人以上；除2項(xiàng)研究的RR未經(jīng)其他危險(xiǎn)因素校正,其余均經(jīng)過(guò)常見(jiàn)的冠心病危險(xiǎn)因素校正。經(jīng)QUADAS質(zhì)量評(píng)價(jià),所選文獻(xiàn)總體質(zhì)量不錯(cuò)。統(tǒng)計(jì)量合并后,壓力所致冠心病的RR是1.25(1.15-1.35)(95%可信區(qū)間),壓力與患冠心病的風(fēng)險(xiǎn)正向相關(guān)。 12=18%,研究基本無(wú)異質(zhì)性。2.動(dòng)物實(shí)驗(yàn)予壓力刺激的大鼠血清中皮質(zhì)酮、hs-CRP、 ICAM-1,主動(dòng)脈中E-選凝素的含量增加,標(biāo)志著炎癥反應(yīng)的發(fā)生；予越鞠丸干預(yù)后,炎癥標(biāo)志物的含量下降,總體來(lái)看,下降幅度與黛力新的效果相似,越鞠丸的療效的劑量效應(yīng)只表現(xiàn)在hs-CRP含量的測(cè)定中。IL-6的含量在各組間無(wú)明顯的差異。結(jié)論：壓力可以增加冠心病發(fā)病的風(fēng)險(xiǎn),可作為冠心病的潛在危險(xiǎn)因素之一。壓力下的大鼠血清中皮質(zhì)酮、CRP和ICAM-1,主動(dòng)脈中E-選凝素的含量增加,標(biāo)志炎癥反應(yīng)的發(fā)生,增加冠心病發(fā)病的風(fēng)險(xiǎn)；予越鞠丸干預(yù)后,炎癥標(biāo)志物的含量下降,總體療效與黛力新類似,越鞠丸的療效無(wú)明顯的劑量效應(yīng)。予壓力應(yīng)激的大鼠體內(nèi)IL-6的含量無(wú)明顯變化�？紤]建模時(shí)間較短,不足以表現(xiàn)出明顯的區(qū)別。
[Abstract]:Purpose 1. The prospective cohort study on the relationship between perceived pressure and coronary heart disease was summarized, and the correlation between perceived pressure and coronary heart disease was studied by meta analysis combined with statistics. To observe the changes of inflammatory reaction markers in serum of rats under pressure, to explore the promoting effect of pressure on the pathogenesis of coronary heart disease from the angle of inflammation, and to observe the intervention effect of traditional Chinese medicine in the occurrence of pressure-induced inflammation with Yueju pills. Further clarify the efficacy of Yueju pill, give full play to the advantages of traditional Chinese medicine, and find an effective way to prevent coronary heart disease caused by stress. Methods: meta analysis: firstly, the inclusion / exclusion criteria of the literature were determined, and then the three foreign language databases, Pubmed, EMBASE, The Cochrane Library, were searched. The retrieval time was from January 1990 to February 2016. The key words were coronary heart disease and psychological stress. After the retrieval, the Endnote software is imported, the results of the retrieval are merged, and the duplicate documents are removed. Select the qualified research, evaluate the quality of the included research, and extract the required information in the research according to the inclusion criteria, and input the data into the Revman5.3 for statistical summary. 2. Animal experiment: divided into blank group, physiological saline group, Yueju pill low dose group, Yueju pill high dose group, Delixin group (western medicine group) 5 groups. Pressure stimulation was given to the latter 4 groups, and the corresponding drugs were given orally once a day for 3 weeks. After that, serum corticosterone IL-6, hs-CRP, sICAM-1 were detected in rat serum and E selectin in aorta. Results one of the 8 studies included in the meta-analysis was the sum of diagnosis and death of coronary heart disease. In two of the eight studies, a common stress measurement scale was used. In the rest of the studies, the subjects were rated for the stress they felt and assigned to different stress groups according to their scores; except for one study, the number of cases was 211. The rest were above 1000, except for the RR of 2 studies which were not adjusted for other risk factors, and the others were adjusted for common risk factors of coronary heart disease. After QUADAS quality evaluation, the overall quality of selected literature is good. The RR of pressure-induced coronary heart disease was 1.25 (1.15-1.35) (95% CI), and the pressure was positively correlated with the risk of coronary heart disease. There is no heterogeneity in the study. The levels of corticosterone hs-CRP, ICAM-1 and E- selectin in aorta were increased in the pressure-stimulated rats, indicating the occurrence of inflammatory reaction, and the content of inflammatory markers decreased after the intervention of Yueju pills. The effect of Yueju pill was similar to that of Delixin. The dose effect of Yueju pill was only found in the determination of hs-CRP content. There was no significant difference in the content of IL-6 between groups. Conclusion: stress can increase the risk of coronary heart disease and may be one of the potential risk factors of coronary heart disease. The levels of corticosterone CRP and ICAM-1 in the serum of rats under pressure increased, indicating the occurrence of inflammatory reaction and increasing the risk of coronary heart disease, and the content of inflammatory markers decreased after the intervention of Yueju pills. The overall efficacy was similar to that of Delixine, and there was no significant dose effect of Yueju pill. There was no significant change in the content of IL-6 in stress rats. Considering the shorter modeling time, it is not enough to show the obvious difference.
【學(xué)位授予單位】：廣州中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：R259
[Abstract]:Purpose 1. The prospective cohort study on the relationship between perceived pressure and coronary heart disease was summarized, and the correlation between perceived pressure and coronary heart disease was studied by meta analysis combined with statistics. To observe the changes of inflammatory reaction markers in serum of rats under pressure, to explore the promoting effect of pressure on the pathogenesis of coronary heart disease from the angle of inflammation, and to observe the intervention effect of traditional Chinese medicine in the occurrence of pressure-induced inflammation with Yueju pills. Further clarify the efficacy of Yueju pill, give full play to the advantages of traditional Chinese medicine, and find an effective way to prevent coronary heart disease caused by stress. Methods: meta analysis: firstly, the inclusion / exclusion criteria of the literature were determined, and then the three foreign language databases, Pubmed, EMBASE, The Cochrane Library, were searched. The retrieval time was from January 1990 to February 2016. The key words were coronary heart disease and psychological stress. After the retrieval, the Endnote software is imported, the results of the retrieval are merged, and the duplicate documents are removed. Select the qualified research, evaluate the quality of the included research, and extract the required information in the research according to the inclusion criteria, and input the data into the Revman5.3 for statistical summary. 2. Animal experiment: divided into blank group, physiological saline group, Yueju pill low dose group, Yueju pill high dose group, Delixin group (western medicine group) 5 groups. Pressure stimulation was given to the latter 4 groups, and the corresponding drugs were given orally once a day for 3 weeks. After that, serum corticosterone IL-6, hs-CRP, sICAM-1 were detected in rat serum and E selectin in aorta. Results one of the 8 studies included in the meta-analysis was the sum of diagnosis and death of coronary heart disease. In two of the eight studies, a common stress measurement scale was used. In the rest of the studies, the subjects were rated for the stress they felt and assigned to different stress groups according to their scores; except for one study, the number of cases was 211. The rest were above 1000, except for the RR of 2 studies which were not adjusted for other risk factors, and the others were adjusted for common risk factors of coronary heart disease. After QUADAS quality evaluation, the overall quality of selected literature is good. The RR of pressure-induced coronary heart disease was 1.25 (1.15-1.35) (95% CI), and the pressure was positively correlated with the risk of coronary heart disease. There is no heterogeneity in the study. The levels of corticosterone hs-CRP, ICAM-1 and E- selectin in aorta were increased in the pressure-stimulated rats, indicating the occurrence of inflammatory reaction, and the content of inflammatory markers decreased after the intervention of Yueju pills. The effect of Yueju pill was similar to that of Delixin. The dose effect of Yueju pill was only found in the determination of hs-CRP content. There was no significant difference in the content of IL-6 between groups. Conclusion: stress can increase the risk of coronary heart disease and may be one of the potential risk factors of coronary heart disease. The levels of corticosterone CRP and ICAM-1 in the serum of rats under pressure increased, indicating the occurrence of inflammatory reaction and increasing the risk of coronary heart disease, and the content of inflammatory markers decreased after the intervention of Yueju pills. The overall efficacy was similar to that of Delixine, and there was no significant dose effect of Yueju pill. There was no significant change in the content of IL-6 in stress rats. Considering the shorter modeling time, it is not enough to show the obvious difference.
【學(xué)位授予單位】：廣州中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：R259
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 鐘光華;越鞠丸加減治療痛證舉隅[J];中國(guó)民間療法;2001年05期
2 成金漢;鄧金強(qiáng);;越鞠丸治療中風(fēng)后抑郁32例[J];臨床醫(yī)藥實(shí)踐;2009年33期
3 李素琴;;越鞠丸加減治療2型糖尿病68例療效觀察[J];山西中醫(yī)學(xué)院學(xué)報(bào);2009年06期
4 朱洪海;;越鞠丸臨床應(yīng)用研究進(jìn)展述略[J];實(shí)用中醫(yī)內(nèi)科雜志;2010年11期
5 王鷹;云端;;越鞠丸臨床運(yùn)用[J];中國(guó)中醫(yī)藥現(xiàn)代遠(yuǎn)程教育;2011年16期
6 吳四平;;淺談“越鞠丸”名方[J];中醫(yī)臨床研究;2011年07期
7 王貝貝;屈艷艷;;越鞠丸治療失眠54例[J];山東中醫(yī)雜志;2012年02期
8 馮笑予;高嵩山;;越鞠丸治療痰濁阻遏型高脂血癥患者療效觀察[J];黑龍江醫(yī)學(xué);2013年09期
9 來(lái)春茂;越鞠丸臨床運(yùn)用經(jīng)驗(yàn)[J];新中醫(yī);1974年05期
10 李志文;;越鞠丸的臨床應(yīng)用[J];吉林中醫(yī)藥;1984年03期
相關(guān)會(huì)議論文 前1條
1 初玉平;張振國(guó);;越鞠丸臨床應(yīng)用舉隅[A];全國(guó)中成藥學(xué)術(shù)研討會(huì)論文匯編[C];1994年
相關(guān)重要報(bào)紙文章 前6條
1 陳良玉;越鞠丸三種新用途[N];醫(yī)藥養(yǎng)生保健報(bào);2006年
2 楊楨邋高琳;靈活辨證治脾胃的范本——越鞠丸[N];中國(guó)醫(yī)藥報(bào);2008年
3 鮑正飛;越鞠丸治療不寐[N];中國(guó)中醫(yī)藥報(bào);2007年
4 亞文;越鞠丸治療不寐[N];農(nóng)村醫(yī)藥報(bào)（漢）;2009年
5 河南省中醫(yī)院 王立忠;六郁與越鞠丸[N];中國(guó)中醫(yī)藥報(bào);2009年
6 王成英;中醫(yī)治郁主調(diào)氣[N];大眾衛(wèi)生報(bào);2004年
相關(guān)碩士學(xué)位論文 前4條
1 王s，
本文編號(hào)：2195104
本文鏈接：http://sikaile.net/zhongyixuelunwen/2195104.html
最近更新
教材專著
